Poster Presentation – Muscular Dystrophy Association Clinical & Scientific Conference March 19 – 22, 2023

Mikalai Malinouski, Senior Director of Portfolio Development and Early Commercial Strategy, gave a talk at the MDA Insights in Research Investor Summit (IRIS) for Neuromuscular Disease. He shared information about our phenomics-driven AI drug discovery approach and programs in Muscular Dystrophy, Charcot-Marie-Tooth Disease, and ALS.